NASDAQ:KRMD

Repro Med Systems Stock Insider Trading

Healthcare > Medical - Instruments & Supplies

Buy KRMD

*Your capital is at risk

$3.92

-0.130 (-3.21%)

At Close: Jun 03, 2026

Repro Med Systems Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.01. In total, the insiders bought 4.69M and sold 1.68M KRMD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	99.01
● Buy	4.69M shares
● Sell	1.68M shares
86% Buy Activity Negligible or No Correlation
Buy Signal High Confidence May 15, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 99.01. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (86% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
May 18, 2026 Buy	Common Stock P-Purchase	Schiller Eric Chief Technology Officer	Officer	5 000 Value: $19.6K
May 15, 2026 Buy	Common Stock P-Purchase	Tharby Linda M Chief Executive Officer	CEO / President	1 191 Value: $1.42M
May 15, 2026 Buy	Common Stock P-Purchase	Tharby Linda M Chief Executive Officer	CEO / President	1 191 Value: $5K
May 14, 2026 Buy	Common Stock M-Exempt	Tharby Linda M Chief Executive Officer	CEO / President	13 977 Value: $55.6K
May 14, 2026 Sell	Common Stock F-InKind	Tharby Linda M Chief Executive Officer	CEO / President	7 326 Value: $28.9K
May 14, 2026 Buy	Common Stock P-Purchase	Pazdan Christopher Chief Operating Officer	C-Suite Officer	5 000 Value: $19.4K
May 14, 2026 Sell	Common Stock F-InKind	Pazdan Christopher Chief Operating Officer	C-Suite Officer	1 470 Value: $6K
May 14, 2026 Buy	Common Stock M-Exempt	Pazdan Christopher Chief Operating Officer	C-Suite Officer	5 327 Value: $21.2K
May 14, 2026 Buy	Common Stock M-Exempt	Adams Thomas Edward Chief Financial Officer	C-Suite Officer	8 193 Value: $32.6K
May 14, 2026 Sell	Common Stock F-InKind	Adams Thomas Edward Chief Financial Officer	C-Suite Officer	2 900 Value: $11.4K
May 14, 2026 Buy	Common Stock P-Purchase	Adams Thomas Edward Chief Financial Officer	C-Suite Officer	459 Value: $2K
May 14, 2026 Buy	Common Stock P-Purchase	Adams Thomas Edward Chief Financial Officer	C-Suite Officer	5 041 Value: $19.5K
Apr 01, 2026 Buy	Common Stock A-Award	Fletcher R John Chairman Of The Board	CEO / President	5 208 Value: $22.5K
Apr 01, 2026 Buy	Common Stock A-Award	Cascella Robert Director	Director	3 472 Value: $15.0K
Apr 01, 2026 Buy	Common Stock A-Award	Wholihan Edward Director	Director	3 472 Value: $15.0K
Apr 01, 2026 Buy	Common Stock A-Award	French Donna Director	Director	3 472 Value: $15.0K
Apr 01, 2026 Buy	Common Stock A-Award	Matin Shahriar Director	Director	3 472 Value: $15.0K
Mar 31, 2026 Buy	Common Stock A-Award	Manko Joseph M. Jr.	Director	3 472 Value: $15.0K
Mar 17, 2026 Buy	Performance Stock Unit A-Award	Adams Thomas Edward Chief Financial Officer	C-Suite Officer	38 918 Value: $166.2K
Mar 17, 2026 Buy	Restricted Stock Unit A-Award	Adams Thomas Edward Chief Financial Officer	C-Suite Officer	38 918 Value: $166.2K
Mar 17, 2026 Buy	Restricted Stock Unit A-Award	Pazdan Christopher Chief Operating Officer	C-Suite Officer	31 226 Value: $133.3K
Mar 17, 2026 Buy	Option to buy Common Stock A-Award	Pazdan Christopher Chief Operating Officer	C-Suite Officer	46 929 Value: $204.1K
Mar 17, 2026 Buy	Option to buy Common Stock A-Award	Kalbermatten Adam R President-chief Commercial Off	CEO / President	67 779 Value: $294.8K
Mar 17, 2026 Buy	Performance Stock Unit A-Award	Kalbermatten Adam R President-chief Commercial Off	CEO / President	45 098 Value: $192.6K
Mar 17, 2026 Buy	Restricted Stock Unit A-Award	Kalbermatten Adam R President-chief Commercial Off	CEO / President	45 098 Value: $192.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT REPRO MED SYSTEMS, INC.

KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training ...

Read Full Profile Here